Overview
PayPoint PLC is a UK-based company that specializes in payment and transactional services. The company provides systems for the processing of consumer payments, particularly in the utilities, telecommunications, and housing sectors, among others.
AI+ Ask Fintel’s AI assistant about PayPoint plc.
Thinking about good questions…
Basic Stats
The share price of PayPoint plc as of March 25, 2024 is $6.10 / share. The market cap (or net worth) of PayPoint plc as of September 5, 2025 is $437.46 MM.
The Factor Analysis chart (below right) shows a view of PayPoint plc from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 437.46 MM |
| EV | |
| Shares Out. | 71.71 MM |
| Earnings Date | |
| EPS (TTM) | 0.27 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-08-28 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | |
| ROE | |
| ROIC | 0.09 |
| CROIC | -0.26 |
| OCROIC | 0.12 |
| Implied Volatility | |
| Put/Call OI Ratio |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for PayPoint plc. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-03-20 | Jefferies | Buy | Reiterate | |
| 2022-11-25 | Barclays | Underweight | Reiterate | |
| 2022-07-21 | Barclays | Underweight | Reiterate | |
| 2022-05-30 | Barclays | Underweight | Reiterate | |
| 2022-05-19 | Barclays | Underweight | Reiterate | |
| 2022-04-20 | Barclays | Underweight | Reiterate | |
| 2022-02-01 | Canaccord Genuity | Reiteration | Reiterate | |
| 2021-12-14 | Barclays | Reiteration | Reiterate | |
| 2021-12-06 | Liberum Capital | Reiteration | Reiterate | |
| 2021-11-25 | Barclays | Reiteration | Reiterate | |
| 2021-11-23 | Liberum Capital | Reiteration | Reiterate | |
| 2021-11-12 | Canaccord Genuity | Buy | Reiterate | |
| 2021-05-27 | Liberum Capital | Buy | Reiterate | |
| 2020-12-14 | Barclays | Underweight | Reiterate | |
| 2015-11-26 | Numis | Hold | Reiterate | |
| 2015-11-26 | Canaccord Genuity | Buy | Reiterate | |
| 2015-07-22 | Numis Securities | Hold | Reiterate | |
| 2015-06-02 | Numis Securities | Hold | Reiterate | |
| 2015-05-22 | Numis Securities | Hold | Reiterate | |
| 2014-12-16 | Liberum Capital | Hold | Reiterate | |
| 2014-12-10 | Liberum Capital | Hold | Reiterate | |
| 2014-12-02 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2014-11-27 | Canaccord Genuity | Buy | Reiterate | |
| 2014-11-26 | Liberum Capital | Hold | Reiterate | |
| 2014-10-31 | Liberum Capital | Hold | Reiterate | |
| 2014-10-24 | Canaccord Genuity | Buy | Reiterate | |
| 2014-10-01 | Canaccord Genuity | Buy | Reiterate | |
| 2014-08-28 | Canaccord Genuity | Buy | Reiterate | |
| 2014-07-24 | Barclays | Equal-weight | Reiterate | |
| 2014-07-23 | Numis Securities | Sell | Reiterate | |
| 2014-07-23 | Canaccord Genuity | Buy | Reiterate | |
| 2014-06-13 | Liberum Capital | Hold | Reiterate | |
| 2014-06-02 | Barclays | Equal-weight | Reiterate | |
| 2014-04-28 | Barclays | Equal-weight | Initiate | |
| 2014-04-11 | Canaccord Genuity | Buy | Reiterate | |
| 2014-03-28 | Jefferies | Buy | Reiterate | |
| 2014-01-24 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2014-01-23 | Jefferies | Buy | Reiterate | |
| 2013-11-27 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2013-11-25 | Liberum Capital | Hold | Reiterate | |
| 2013-11-21 | Canaccord Genuity | Buy | Reiterate | |
| 2013-11-21 | Numis Securities | Sell | Reiterate | |
| 2013-11-21 | Jefferies | Buy | Reiterate | |
| 2013-09-06 | Liberum Capital | Hold | Reiterate | |
| 2013-07-24 | Numis Securities | Sell | Reiterate | |
| 2016-09-29 | Numis | Hold | Reiterate | |
| 2016-09-29 | Jefferies | Buy | Reiterate | |
| 2016-07-29 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2016-07-26 | Canaccord Genuity | Buy | Reiterate | |
| 2016-06-07 | Canaccord Genuity | Buy | Reiterate | |
| 2016-05-27 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2016-05-26 | Canaccord Genuity | Buy | Reiterate | |
| 2016-03-24 | Numis | Hold | Reiterate | |
| 2016-01-29 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2015-11-27 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2020-10-26 | Canaccord Genuity | Buy | Reiterate | |
| 2020-07-22 | Canaccord Genuity | Buy | Reiterate | |
| 2020-05-28 | Canaccord Genuity | Buy | Reiterate | |
| 2019-09-12 | Canaccord Genuity | Buy | Reiterate | |
| 2019-08-05 | Canaccord Genuity | Buy | Reiterate | |
| 2019-07-01 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2019-06-28 | Canaccord Genuity | Buy | Reiterate | |
| 2019-05-29 | Liberum Capital | Buy | Reiterate | |
| 2017-11-28 | Canaccord Genuity | Buy | Reiterate | |
| 2017-11-16 | Jefferies | Buy | Reiterate | |
| 2017-06-16 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2017-05-09 | Barclays | Underweight | Reiterate | |
| 2017-01-27 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2017-01-26 | Numis | Hold | Reiterate | |
| 2017-01-26 | Canaccord Genuity | Buy | Reiterate | |
| 2017-01-16 | Canaccord Genuity | Buy | Reiterate | |
| 2016-12-16 | Numis | Hold | Reiterate | |
| 2016-12-16 | Canaccord Genuity | Buy | Reiterate | |
| 2016-11-25 | Barclays | Equal-weight | Reiterate | |
| 2016-11-24 | Numis | Hold | Reiterate | |
| 2016-10-17 | Barclays | Equal-weight | Reiterate | |
| 2013-07-24 | Canaccord Genuity | Buy | Reiterate |
